Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:2198-2205
Published online before print April 15, 2002, doi: 10.1161/01.CIR.0000015603.84788.47
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/18/2198    most recent
01.CIR.0000015603.84788.47v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalra, D.
Right arrow Articles by Mann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalra, D.
Right arrow Articles by Mann, D. L.
Related Collections
Right arrow Gene expression
Right arrow Growth factors/cytokines
Right arrow Heart failure - basic studies

(Circulation. 2002;105:2198.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C–Dependent Pathway

Dinesh Kalra, MD; Natarajan Sivasubramanian, PhD; Douglas L. Mann, MD

From Winters Center for Heart Failure Research, Cardiology Section, Department of Medicine, Veterans Administration Medical Center, and Baylor College of Medicine, Houston, Tex.

Correspondence to Douglas L. Mann, MD, Winters Center, M5524, 6565 Fannin, Houston, TX 77030. E-mail dmann{at}bcm.tmc.edu

Background Previous studies suggest that angiotensin II (Ang II) upregulates the expression of tumor necrosis factor (TNF) in nonmyocyte cell types; however, the effect of Ang II on TNF expression in the adult mammalian heart is not known.

Methods and Results To determine whether Ang II was sufficient to provoke TNF biosynthesis in the adult heart, we examined the effects of Ang II in isolated buffer-perfused Langendorff feline hearts. Ang II (10-7 mol/L) treatment resulted in a time- and dose-dependent increase in myocardial TNF mRNA and protein biosynthesis in the heart as well as in cultured adult cardiac myocytes. The effects of Ang II on myocardial TNF mRNA and protein synthesis were mediated through the angiotensin type 1 receptor (AT1R), insofar as an AT1R antagonist (AT1a) blocked the effects of Ang II, whereas an angiotensin type 2 receptor (AT2R) antagonist (AT2a) had no effect. Stimulation with Ang II led to the activation of nuclear factor-{kappa}B and activator protein-1 (AP-1), two transcription factors that are important for TNF gene expression. Nuclear factor-{kappa}B activation was accompanied by phosphorylation of I{kappa}B{alpha} on serine 32 as well as degradation of I{kappa}B{alpha}, suggesting that the effects of Ang II were mediated through an I{kappa}B{alpha}-dependent pathway. The important role of protein kinase C (PKC) was suggested by studies in which a phorbol ester triggered TNF biosynthesis, and a PKC inhibitor abrogated Ang II–induced TNF biosynthesis.

Conclusions These studies suggest that Ang II provokes TNF biosynthesis in the adult mammalian heart through a PKC-dependent pathway.


Key Words: heart failure • angiotensin • genes • growth substances • proteins




This article has been cited by other articles:


Home page
HypertensionHome page
S. Sriramula, M. Haque, D. S.A. Majid, and J. Francis
Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy
Hypertension, May 1, 2008; 51(5): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Deschamps, J. Zavadzkas, R. L. Murphy, C. N. Koval, J. E. McLean, L. Jeffords, S. M. Saunders, N. J. Sheats, R. E. Stroud, and F. G. Spinale
Interruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusion
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H875 - H883.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Wang, P. Paradis, A. Aries, H. Komati, C. Lefebvre, H. Wang, and M. Nemer
Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4
Mol. Cell. Biol., November 15, 2005; 25(22): 9829 - 9844.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kawano, T. Kubota, Y. Monden, N. Kawamura, H. Tsutsui, A. Takeshita, and K. Sunagawa
Blockade of NF-{kappa}B ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II
Cardiovasc Res, September 1, 2005; 67(4): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Sekiguchi, X. Li, M. Coker, M. Flesch, P. M Barger, N. Sivasubramanian, and D. L Mann
Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure
Cardiovasc Res, August 15, 2004; 63(3): 433 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. A. Arenas, Y. Xu, P. Lopez-Jaramillo, and S. T. Davidge
Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-{alpha}
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C779 - C784.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Ichikawa, T. Miura, A. Nakano, T. Miki, Y. Nakamura, K. Tsuchihashi, and K. Shimamoto
The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning
Cardiovasc Res, April 1, 2004; 62(1): 167 - 175.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Yamamoto, T. Shioi, K. Uchiyama, T. Miyamoto, S. Sasayama, and A. Matsumori
Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. El Bekay, M. Alvarez, J. Monteseirin, G. Alba, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Pintado, F. J. Bedoya, et al.
Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-{kappa}B
Blood, July 15, 2003; 102(2): 662 - 671.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Frantz, D. Fraccarollo, H. Wagner, T. M Behr, P. Jung, C. E Angermann, G. Ertl, and J. Bauersachs
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure
Cardiovasc Res, March 1, 2003; 57(3): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
B. Schieffer
Interaction of interleukin-6 and angiotensin II in atherosclerosis: culprit for inflammation?
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A25 - A30.
[Abstract] [PDF]


Home page
Circ. Res.Home page
J. Peng, D. Gurantz, V. Tran, R. T. Cowling, and B. H. Greenberg
Tumor Necrosis Factor-{alpha}-Induced AT1 Receptor Upregulation Enhances Angiotensin II-Mediated Cardiac Fibroblast Responses That Favor Fibrosis
Circ. Res., December 13, 2002; 91(12): 1119 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
B. J. Holycross and M. J. Radin
Cytokines in Heart Failure: Potential Interactions with Angiotensin II and Leptin
Mol. Interv., November 1, 2002; 2(7): 424 - 427.
[Abstract] [Full Text]


Home page
Eur Heart J SupplHome page
J. Soler-Soler and D. Garcia-Dorado
How to best to counteract the enemies? By blocking neurohormonal activation
Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G45 - G50.
[Abstract] [PDF]